Arrive AI, Inc. Files Restated Quarterly Report: Critical Information for Investors

Overview

Arrive AI, Inc. (“Arrive” or “the Company”) has filed Amendment No. 1 to its Quarterly Report on Form 10-Q/A for the period ended June 30, 2025. This amendment was submitted to correct significant accounting errors identified in the original quarterly filing, which may have material impacts for shareholders and could affect the Company’s share price.

Key Points

• Restatement Triggered by Accounting Errors: Management, in consultation with the Company’s independent registered public accounting firm, identified errors related to the accounting of hybrid financial instruments issued under a Securities Purchase Agreement dated March 21, 2025, with Streeterville Capital, LLC. Specifically, embedded conversion features were not properly bifurcated and accounted for as derivative liabilities at fair value, as required by ASC 815. Furthermore, original issue discounts and debt issuance costs were not correctly accreted using the effective interest method.
• Financial Statements Restated: The Company’s Audit Committee concluded that the previously issued financial statements for the quarter ended June 30, 2025, should no longer be relied upon. The restatement affects the condensed balance sheet, statements of operations and comprehensive loss, statements of stockholders’ equity (deficit), statements of cash flows, and related notes for the three and six months ended June 30, 2025.
• Material Weakness in Internal Controls: The restatement also led to management revising its conclusions regarding the effectiveness of disclosure controls and internal control over financial reporting (ICFR) as of June 30, 2025. A material weakness in ICFR was identified in connection with the restatement.
• Shareholder Structure and Securities: As of August 14, 2025, Arrive AI had 33,025,649 shares of common stock outstanding, with a par value of \$0.0002 per share. The stock trades under the symbol “ARAI” on the Nasdaq Stock Market LLC.
• Company Category: Arrive AI is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company.
• Certifications Updated: The amendment includes updated certifications from the principal executive officer and principal financial officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002.
• No Other Updates: Except for the corrections and updates described above, the Form 10-Q/A does not amend, modify, or update other disclosures from the original filing, and continues to speak as of the date of the original report.

Details Shareholders Must Know

• Restatement Implications: The identification and correction of accounting errors in the treatment of hybrid financial instruments and related derivatives are significant. Such restatements can impact investor confidence, potentially affect the Company’s valuation, and may trigger regulatory or market scrutiny.
• Material Weakness in Internal Controls: The disclosure of a material weakness in the Company’s internal controls over financial reporting is a red flag for investors. This could affect management’s credibility and might impact future financial disclosures or the Company’s ability to raise capital.
• Stock Issuances: During the six months ended June 30, 2025, Arrive AI issued shares through various mechanisms:
  • Issuance of common stock, net: 2,941,039 shares in the second quarter, and 33,846 shares in the first quarter.
  • Issuance of common stock upon exercise of warrants: 58,320 shares in Q2, 62,500 shares in Q1.
  • Issuance of common stock for deferred offering costs and stock-based compensation.
• Financial Performance: The Company’s net loss per share for Q2 2025 was \$0.12, which was higher than the net loss per share of \$0.08 for the same period in 2024, indicating increased losses. The accumulated deficit as of June 30, 2025, was \$17,587,791, an increase from \$15,920,555 at year-end 2024, showing continued negative operating results.
• Stockholders’ Equity: The Company’s stockholders’ equity improved to \$4,489,417 as of June 30, 2025, compared to a deficit of \$983,175 at year-end 2024, likely reflecting new capital infusions and stock issuances.
• Reporting Status: Arrive AI has complied with all SEC reporting requirements and submitted all interactive data files required for the past 12 months. The Company is not a shell company and has not elected the extended transition period for complying with new or revised financial accounting standards.

Potential Price-Sensitive Information

• Restatement of Financials: Restatements are often viewed negatively by the market, as they suggest prior inaccuracies and possible management oversight. The material weakness in internal controls is especially notable and may lead to downward pressure on the share price until confidence is restored.
• Updated Share Structure and Equity: The significant increase in stockholders’ equity, along with the issuance of millions of shares, may dilute existing shareholders but also signals new capital inflows. The overall financial health and capital structure changes are important for valuation and pricing.
• Continued Net Losses: The Company continues to report substantial net losses, which may concern investors regarding profitability and sustainability.

Additional Information

• Legal Proceedings, Risk Factors, and Other Disclosures: The amendment updates sections on controls and procedures, risk factors, and includes management’s discussion and analysis reflecting the impact of the restatement on financial condition and liquidity. Legal proceedings and risk factors may also be updated.
• Exhibits: The amendment includes updated certifications as required by the Sarbanes-Oxley Act.

Conclusion

The restatement of Arrive AI, Inc.’s quarterly financials and the identification of a material weakness in internal controls are highly significant for investors. These issues may influence the Company’s share price in the near term as the market digests the implications. Investors should closely monitor future filings and management actions to address these weaknesses.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. The information herein is based on the latest publicly available filings from Arrive AI, Inc. and may be subject to change. Past performance is not indicative of future results.

View Arrive AI Inc. Historical chart here